Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
Clinical trial NCT04168931 · TERMINATED
Trial details
- NCT number
- NCT04168931
- Sponsor
- AC Camargo Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2023-01-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.